WO1996011448A1 - Improved accuracy in cell mitosis analysis - Google Patents
Improved accuracy in cell mitosis analysis Download PDFInfo
- Publication number
- WO1996011448A1 WO1996011448A1 PCT/US1995/012746 US9512746W WO9611448A1 WO 1996011448 A1 WO1996011448 A1 WO 1996011448A1 US 9512746 W US9512746 W US 9512746W WO 9611448 A1 WO9611448 A1 WO 9611448A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- histogram
- peak
- cells
- channel
- phase
- Prior art date
Links
- 238000004458 analytical method Methods 0.000 title description 10
- 230000011278 mitosis Effects 0.000 title description 7
- 238000000034 method Methods 0.000 claims abstract description 34
- 230000006870 function Effects 0.000 claims abstract description 32
- 230000018199 S phase Effects 0.000 claims abstract description 26
- 230000035519 G0 Phase Effects 0.000 claims abstract description 14
- 238000005259 measurement Methods 0.000 claims abstract description 14
- 230000009131 signaling function Effects 0.000 claims abstract description 13
- 230000010337 G2 phase Effects 0.000 claims abstract description 12
- 230000000295 complement effect Effects 0.000 claims abstract description 4
- 239000007850 fluorescent dye Substances 0.000 claims abstract description 4
- 230000003362 replicative effect Effects 0.000 claims abstract description 3
- 208000036878 aneuploidy Diseases 0.000 claims description 35
- 230000003322 aneuploid effect Effects 0.000 claims description 33
- 238000009826 distribution Methods 0.000 claims description 11
- 238000012360 testing method Methods 0.000 claims description 6
- 239000000975 dye Substances 0.000 claims description 5
- 238000010186 staining Methods 0.000 claims description 2
- 238000012935 Averaging Methods 0.000 claims 2
- 238000000926 separation method Methods 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 description 83
- 239000000523 sample Substances 0.000 description 11
- 206010028980 Neoplasm Diseases 0.000 description 5
- 201000011510 cancer Diseases 0.000 description 5
- 238000000149 argon plasma sintering Methods 0.000 description 4
- 238000011161 development Methods 0.000 description 4
- 238000007619 statistical method Methods 0.000 description 4
- 238000004393 prognosis Methods 0.000 description 3
- 230000001419 dependent effect Effects 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- 238000011179 visual inspection Methods 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 238000000684 flow cytometry Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000013179 statistical model Methods 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/10—Investigating individual particles
- G01N15/14—Optical investigation techniques, e.g. flow cytometry
- G01N15/1456—Optical investigation techniques, e.g. flow cytometry without spatial resolution of the texture or inner structure of the particle, e.g. processing of pulse signals
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/645—Specially adapted constructive features of fluorimeters
- G01N21/6456—Spatial resolved fluorescence measurements; Imaging
- G01N21/6458—Fluorescence microscopy
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/10—Investigating individual particles
- G01N15/14—Optical investigation techniques, e.g. flow cytometry
- G01N2015/1486—Counting the particles
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/808—Optical sensing apparatus
Definitions
- This invention relates to cytometric measurement of DNA content of cells for the determination of cell mitosis, in the prognosis of cancer stages and development.
- the cells are generally categorized into three classes or "populations":
- Physicians and oncologists find that a percentage determination of the cells in each phase is useful in a prognosis of a patient's cancer development, since efficacy of different treatments is dependent on the stage of cancer development.
- a cell population with more cells in the S and G 2 phases is indicative of a faster rate of cell mitosis and a probably more serious malignant state.
- a dye absorption property of DNA has been utilized, in devices and developed procedures, to discriminate between the various cell types or classes. This permits calculation of the percentages of cells, contained in each of the aforementioned populations, in large scale cell analysis.
- fluorescent dyes are used to stain the cells, with the dye being taken up only by the DNA in the cells. Scanning of the cells with a laser excites the dye to fluoresce, with the amount of light thus obtained from each cell being roughly proportional to the DNA content of the cell.
- a cytometer or flow cytometer (using a stationary slide sample of cells and a cell-aligned flowing cell sample, respectively) is used to effect such fluorescing, light measurement, and proportional determination of percentage cells with different DNA content.
- Characteristics of flow cytometers are described, for example in Characteristics of Flow Cytometers by Harald B. Steen in Flow Cytometrv and Sorting, pp 11-25 (Wiley-Liss, Inc. 1990, 2nd ed.), the disclosure of which is incorporated herein by reference thereto.
- a microscope based, stationary sample cytometer is disclosed in US Patent Nos. 5,072,382 and 5,107,422, issued to Louis A. Kamentsky, the disclosure of which is also incorporated herein by reference thereto.
- the distributions of cell populations of the histograms have been analyzed using standard statistical methods. With such methods, the errors in each of the G 0 and G 2 phases are modelled as Gaussian, with a constant coefficient of variation.
- the S phase has been modeled in a number of different ways: as a first or second degree polynomial, or as a series of trapezoids. A least squares fit is applied to the model to arrive at the actual population counts of the three phases (as described in "Data Processing", by Phillip N. Dean, Flow Cytometry and Sorting, second ed. , pages 415-444 (Wiley- Liss, Inc. 1990) ) .
- Figures la and lb are schematic depictions of a flow cytometer and a microscope based cytometer respectively.
- Figure 2 is a flow chart and description of the creation of a typical histogram from cytometric measurements and analysis
- Figure 3 is a typical initial histogram with G 0 and G 2 peaks and S region
- Figures 4-13 depict the stepwise deconvolving and reconvolving of histograms with Gaussian error function for accurate determination of G 0 and G 2 peaks and S region;
- Figure 14 is a combined histogram of the corrected G 0 and G 2 peaks and S region determined in Figures 4-13;
- Figure 15 is an histogram of the same sample, corrected for errors in accordance with prior art statistical methods
- Figure 16 is an histogram with hidden aneuploid peak
- Figure 17 is the histogram of Figure 16, with the aneuploid and diploid peaks being visually separated.
- the present invention comprises a method for the determination, with greater accuracy, of relative percentage populations of cells in biological samples, such as blood cell samples, having varying complements of DNA, ranging from a baseline complement of DNA, in normal cells, to cells having two full complements of DNA, prior to splitting into two cells.
- the method of the present invention comprises the steps of: a) staining a testing sample of cells with a fluorescent dye which is taken up only by the DNA within the individual cells; b) using fluorescing means, such as a laser, to excite the taken up dye within the cells, whereby light is emitted from the individual cells, in substantial proportion to the DNA content therewithin; c) measuring the emitted light relative to the number of cells within the testing sample and relating the measured light to DNA content within said cells; d) preparing an histogram of relative cell populations of said testing sample having different DNA contents; e) modeling the relation of the number of cells, as determined by the florescence measurements, with a DNA content of a specified value (signal function) , relative to an error function inherent in said measurements; for each of the cell populations with differing DNA contents; and d) deconvoluting the error function from the signal function with deconvolution means and correcting the histogram at each of the differing DNA contents populations to reflect substantially only the signal function.
- the prior art statistical method postulates a function S(x'), with variable coefficients and computes these coefficients so as to minimize the difference between the integral and the observed histogram H(x) , with the assumption that the coefficients are optimally adjusted by finding the minimum.
- a fallacy in such assumption exists in that those elements of S(x') that have more coefficients (e.g., the S phase in a second order polynomial model have three coefficients) will tend to have disproportionately more cells assigned to them than those elements that have less coefficients (e.g., G 0 which has one coefficient) . It is thus possible that with such prior art analysis, at least half of the cells of the G 0 and G 2 phases are assigned to the S phase.
- the signal function defined as representing the number of cells with a DNA of a particular value, is modeled with its interaction with an error function at that value (the error function, for example, resulting from statistical errors, focusing problems, inaccurat measurement of background, etc.) in a convolution of the signal function S by the error function E, as described and represente as above.
- the cell distribution S(x) is derived from the histogram H(x) and the error function (E ⁇ x) , by taking the inverse fast
- the fast Fourier transform o the histogram divided by the fast Fourier transform of the erro function.
- the transforms are performed in a piecewise analysis or deconvolution, using a standard deviation equal to the constant coefficient of variation (COV) times the DNA value at Giata.
- COV constant coefficient of variation
- the G 0 peak that becomes apparent is subtracted out of the histogram.
- the transforms are performed at G 2 an the peak is subtracted out at that location.
- the deconvolution obtained in this manner most commonly assumes a Gaussian error function, with a standard deviation being that of the leading edge of the G 0 peak.
- Deconvolution, in accordanc with the present invention is equally applicable to any error function convoluted with a signal function and, is accordingly not limited to only a Gaussian error function.
- measurement of the inherent machine error function may be made by using a sample of cells which are all in the G 0 state. The histogram of integrated fluorescence would be the machine's error function. This error function is then substituted for the Gaussian during deconvolution and reconvolution.
- the error function is not a perfect Gaussian and accordingly, the G 0 peak so derived is not a perfect delta function.
- the histogram may therefore exhibit "ringing" (negative deviation of the peak) due to a COV estimate which is too high. Accordingly, it is heuristically assumed that the G 0 portion of the deconvoluted histogram extends 8% to either side of the G 0 peak, with the percentage being invariant with respect to the COV in the deconvoluted domain.
- the heuristic creates two histograms: (a) a histogram of the cells in the G 0 phase in the deconvoluted domain (G Q Phase(x)), and (b) a histogram of the cells that are not in the G 0 phase in the deconvoluted domain ( ⁇ G 0 Phase(x) ) .
- g(H'W) S'(x) ST 1 ( S(E'( ⁇ x) )
- E' ( ⁇ x) is a Gaussian whose standard deviation is twice that of E( ⁇ x) since the G 2 population has twice the DNA as the G framework population.
- the constant COV is assumed to be twice that of the G 0 population (with flow cytometers, having a non-linearity of measurement, the measured G 2 fluorescence is about 195% of the G 0 and this percentage difference is used with flow cytometer measurements) .
- the same heuristic percentage is utilized as in the G 0 phase in order to find the cell counts in the G 2 and S populations.
- the above method is also applicable to histograms of aneuploid populations (populations of cells in which some of the cells have incorrectly manufactured multiple copies of some of their DNA) in order to obtain accurate cell counts of aneuploid populations.
- the aneuploid peak however rides on top of the S phase for non-aneuploid cells.
- the S phase is subtracted from the aneuploid peak in order to obtain the correct cell count for the aneuploid peak.
- Figure la shows a cytometer with a flowing cell suspension passing between a light source excitation beam, a light scattering detector, and a fluorescing collection lens.
- Light scattering detector and fluorescence detector collect respective detected outputs of fluorescence and light scattering, with appropriate electronics, converting the detected data into a histogram.
- Figure lb Figure 1 therein a microscope 16 with a movable stage is used to scan a slide 28 have a cell specimen thereon.
- the specimen is illuminated and fluoresced by light source 12, with sensors 20 and 22 sensing light scattering and sensors 24 and 26 sensing fluorescing whereby a histogram is created from the detected light.
- a histogram array is created by the analysis of cells, as shown in the flow chart, based on the integrated fluorescence of the cells, as obtained from a cytometer such as in Figures la or lb.
- Each element of the cell list contains a record of the cell's integrated fluorescence.
- An histogram array is created in memory and it is composed of 200 channels or array elements. The histogram elements are initialized to zero.
- Channel N of the histogram will contain the number of cells in the cell list whose integrated fluorescence is between Scale*N and Scale*(N+l).
- a next cell is selected from the cell list until there are no more cells in the list.
- the histogram contains the counts of cells in its channels.
- COV constant coefficient of variation
- the histogram from channel 0 to the cutting channel is the deconvolved G 0 peak of Figure 6, with the histogram from the cutting channel to channel 199 being the deconvolved G 2 peak and S region, as shown in Figure 7; 6. multiplying the fast Fourier transform of the deconvolved G 0 peak by the fast Fourier transform of the Gaussian and then taking the inverse fast Fourier transform of the result to get the G 0 portion of the original histogram, as shown in Figure 8; 7. creating a second Gaussian histogram whose standard deviation is twice that of the original Gaussian;
- a combined histogram of the reconvolved G 0 , G 2 and S is prepared for the mitosis analysis, as shown in Figure 14.
- An error corrected histogram ( Figure 15) prepared in accordance with the procedure of the prior art significantly differs from a histogram with results which would be expected to be obtained by an actual visual inspection of the cell data of distribution in the same sample.
- the populations are 71.0% in the G 0 phase, 17% in the G 2 phase and 12% in the S phase with a fitting COV of 4.8%.
- Figure 16 is an histogram with an aneuploid peak which is hidden because of a large COV.
- the deconvolution method of the present invention (depicted in the histogram of Figure 17) the aneuploid peak 10 is clearly separated from the diploid peak 11.
- step (d) a minimum of the numbers obtained in (b) and (c) is then taken and this accounts for an aneuploid peak that is very close to either G 0 or G 2 .
- the left average includes cells in the G 0 and S phases.
- the right average includes cells in the G 2 and S phases;
- the number obtained in step (d) is then substracted from all of the channel counts from 8% to the left of the peak to 8% to the right of the peak;
- the histogram comprising the channel counts from 8% to the left to 8% to the right of the peak, is reconvolved to get the aneuploid peak, which is then subtracted from the original histogram.
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Wood Science & Technology (AREA)
- Urology & Nephrology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Tropical Medicine & Parasitology (AREA)
- Optics & Photonics (AREA)
- Dispersion Chemistry (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cell Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
Claims
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP8512646A JPH10508690A (en) | 1994-10-05 | 1995-10-05 | Improved accuracy in analyzing cell mitosis |
EP95938147A EP0793830A4 (en) | 1994-10-05 | 1995-10-05 | Improved accuracy in cell mitosis analysis |
AU38889/95A AU3888995A (en) | 1994-10-05 | 1995-10-05 | Improved accuracy in cell mitosis analysis |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/318,233 US5633945A (en) | 1994-10-05 | 1994-10-05 | Accuracy in cell mitosis analysis |
US08/318,233 | 1994-10-05 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1996011448A1 true WO1996011448A1 (en) | 1996-04-18 |
Family
ID=23237281
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1995/012746 WO1996011448A1 (en) | 1994-10-05 | 1995-10-05 | Improved accuracy in cell mitosis analysis |
Country Status (7)
Country | Link |
---|---|
US (1) | US5633945A (en) |
EP (1) | EP0793830A4 (en) |
JP (1) | JPH10508690A (en) |
AU (1) | AU3888995A (en) |
CA (1) | CA2201868A1 (en) |
IL (1) | IL115506A (en) |
WO (1) | WO1996011448A1 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004088574A1 (en) * | 2003-04-02 | 2004-10-14 | Amersham Biosciences Uk Limited | Method of, and computer software for, classification of cells into subpopulations |
WO2007076188A2 (en) | 2005-12-20 | 2007-07-05 | Beckman Coulter, Inc. | Systems and methods for particle counting |
US9448228B2 (en) | 2012-06-15 | 2016-09-20 | Nihon Kohden Corporation | Cell analyzing apparatus and cell analyzing method |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000026666A2 (en) * | 1998-10-29 | 2000-05-11 | Cell Works Inc. | Multiple marker characterization of single cells |
AU2876900A (en) | 1999-02-10 | 2000-08-29 | Cell Works Inc. | Class characterization of circulating cancer cells isolated from body fluids andmethods of use |
US7369304B2 (en) * | 1999-10-29 | 2008-05-06 | Cytyc Corporation | Cytological autofocusing imaging systems and methods |
US7153691B2 (en) * | 2002-11-13 | 2006-12-26 | G6 Science Corp. | Method of identifying and assessing DNA euchromatin in biological cells for detecting disease, monitoring wellness, assessing bio-activity, and screening pharmacological agents |
US7706590B2 (en) * | 2004-01-28 | 2010-04-27 | Compucyte Corporation | Method and device for interrogating samples using laser scanning cytometry and other techniques |
CA2576510C (en) | 2004-08-06 | 2014-10-14 | Compucyte Corporation | Multiple-color monochromatic light absorption and quantification of light absorption in a stained sample |
US8101368B2 (en) * | 2006-02-13 | 2012-01-24 | Dvs Sciences Inc. | Quantitation of cellular DNA and cell numbers using element labeling |
EP2156370B1 (en) * | 2007-05-14 | 2011-10-12 | Historx, Inc. | Compartment segregation by pixel characterization using image data clustering |
EP2162728B1 (en) * | 2007-06-15 | 2016-07-27 | Novartis AG | Microscope system and method for obtaining standardized sample data |
CA2604317C (en) | 2007-08-06 | 2017-02-28 | Historx, Inc. | Methods and system for validating sample images for quantitative immunoassays |
CA2596204C (en) * | 2007-08-07 | 2019-02-26 | Historx, Inc. | Method and system for determining an optimal dilution of a reagent |
WO2009029810A1 (en) * | 2007-08-31 | 2009-03-05 | Historx, Inc. | Automatic exposure time selection for imaging tissue |
WO2010033508A1 (en) * | 2008-09-16 | 2010-03-25 | Historx, Inc. | Reproducible quantification of biomarker expression |
US8154273B2 (en) * | 2008-10-10 | 2012-04-10 | Beckman Coulter, Inc. | Detecting and handling coincidence in particle analysis |
JP6226663B2 (en) * | 2013-09-19 | 2017-11-08 | 日本光電工業株式会社 | Cell analysis device and cell analysis method |
JP6784507B2 (en) * | 2016-04-26 | 2020-11-11 | 日本光電工業株式会社 | Cancer diagnostic equipment, cancer diagnostic methods, and programs |
US11799487B2 (en) * | 2021-03-23 | 2023-10-24 | Ningbo Aura Semiconductor Co., Limited | Fractional sampling-rate converter to generate output samples at a higher rate from input samples |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5107422A (en) * | 1989-10-02 | 1992-04-21 | Kamentsky Louis A | Method and apparatus for measuring multiple optical properties of biological specimens |
US5202230A (en) * | 1990-09-07 | 1993-04-13 | Kamentsky Louis A | Methods of detecting cut cells in a tissue section |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4780406A (en) * | 1983-10-18 | 1988-10-25 | The Regents Of The University Of California | Flow cytometric measurement of total DNA and incorporated halodeoxyuridine |
-
1994
- 1994-10-05 US US08/318,233 patent/US5633945A/en not_active Expired - Fee Related
-
1995
- 1995-10-03 IL IL11550695A patent/IL115506A/en not_active IP Right Cessation
- 1995-10-05 WO PCT/US1995/012746 patent/WO1996011448A1/en not_active Application Discontinuation
- 1995-10-05 JP JP8512646A patent/JPH10508690A/en active Pending
- 1995-10-05 AU AU38889/95A patent/AU3888995A/en not_active Abandoned
- 1995-10-05 CA CA002201868A patent/CA2201868A1/en not_active Abandoned
- 1995-10-05 EP EP95938147A patent/EP0793830A4/en not_active Withdrawn
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5107422A (en) * | 1989-10-02 | 1992-04-21 | Kamentsky Louis A | Method and apparatus for measuring multiple optical properties of biological specimens |
US5202230A (en) * | 1990-09-07 | 1993-04-13 | Kamentsky Louis A | Methods of detecting cut cells in a tissue section |
Non-Patent Citations (4)
Title |
---|
IEEE TRANSACTIONS ON NUCLEAR SCIENCE, Vol. ns-21, No. 1, February 1974, MARVIN A. VAN DILLA et al., "High Speed Cell Analysis and Sorting With Flow Systems: Biological Applications and New Approaches", pages 714-720. * |
JOURNAL OF MICROSCOPY, Volume 156, Part 3, December 1989, J.P. RIGAUT et al., "The 'Corpuscle' Stereological Problem--Reevaluation Using Slab Fragment Volumes and Application to the Correction of DNA Histograms from Sections of pherical Nuclei", pages 371-382. * |
PROC. OF THE 7TH IFAC/IFORS SYMPOSIUM, Vol. 1, Published 1985, F.W. SCHULTZ et al., "Identification of the Flow Cytometry System for DNA Histogram Analysis Purposes", pages 1131-1136. * |
See also references of EP0793830A4 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004088574A1 (en) * | 2003-04-02 | 2004-10-14 | Amersham Biosciences Uk Limited | Method of, and computer software for, classification of cells into subpopulations |
WO2007076188A2 (en) | 2005-12-20 | 2007-07-05 | Beckman Coulter, Inc. | Systems and methods for particle counting |
EP1969362A4 (en) * | 2005-12-20 | 2018-01-03 | Beckman Coulter, Inc. | Systems and methods for particle counting |
US9448228B2 (en) | 2012-06-15 | 2016-09-20 | Nihon Kohden Corporation | Cell analyzing apparatus and cell analyzing method |
Also Published As
Publication number | Publication date |
---|---|
JPH10508690A (en) | 1998-08-25 |
CA2201868A1 (en) | 1996-04-18 |
EP0793830A1 (en) | 1997-09-10 |
US5633945A (en) | 1997-05-27 |
IL115506A (en) | 2000-02-17 |
AU3888995A (en) | 1996-05-02 |
EP0793830A4 (en) | 2000-07-26 |
IL115506A0 (en) | 1996-01-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5633945A (en) | Accuracy in cell mitosis analysis | |
Dean et al. | Cell‐cycle analysis using a monoclonal antibody to BrdUrd | |
Tung et al. | New approaches to fluorescence compensation and visualization of FACS data | |
Bossinger et al. | Quantitative analysis of two-dimensional electrophoretograms. | |
US5556764A (en) | Method and apparatus for cell counting and cell classification | |
US6235536B1 (en) | Analysis of quiescent anticoagulated whole blood samples | |
US7881517B2 (en) | Method of analysing cell samples, by creating and analysing a resultant image | |
EP0421736B1 (en) | Method and apparatus for measuring optical properties of biological specimens | |
US4741043A (en) | Method of and an apparatus for image analyses of biological specimens | |
US4596464A (en) | Screening method for red cell abnormality | |
Martin-Reay et al. | Evaluation of a new slide-based laser scanning cytometer for DNA analysis of tumors: Comparison with flow cytometry and image analysis | |
US9607372B2 (en) | Automated bone marrow cellularity determination | |
US20200080928A1 (en) | System and apparatus for blind deconvolution of flow cytometer particle emission | |
Patton | Biologist's perspective on analytical imaging systems as applied to protein gel electrophoresis | |
Baldetorp et al. | Reproducibility in DNA flow cytometric analysis of breast cancer: comparison of 12 laboratories' results for 67 sample homogenates | |
Puech et al. | Standardisation of DNA quantitation by image analysis: quality control of instrumentation | |
Rolke et al. | Size structure analysis of zooplankton samples by means of an automated image analyzing system | |
EP0633462A2 (en) | Three-color flow cytometry with automatic gating function | |
Méhes et al. | Quantitative analysis of disseminated tumor cells in the bone marrow by automated fluorescence image analysis | |
WO1994029800A9 (en) | Three-color flow cytometry with automatic gating function | |
Tucker | An image analysis system for cervical cytology automation using nuclear DNA content. | |
EP0679889A2 (en) | A method and an apparatus for particle image analysis | |
Böcker et al. | Automated cell cycle analysis with fluorescence microscopy and image analysis | |
EP0375201B1 (en) | A method of separating the three major types of blood cells from a white blood cell histogram | |
EP0138591A2 (en) | Screening method for red blood cell abnormality |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AM AT AU BB BG BR BY CA CH CN CZ DE DK EE ES FI GB GE HU IS JP KE KG KP KR KZ LK LR LT LU LV MD MG MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TT UA UG UZ VN |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): KE MW SD SZ UG AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
ENP | Entry into the national phase |
Ref document number: 2201868 Country of ref document: CA Ref country code: CA Ref document number: 2201868 Kind code of ref document: A Format of ref document f/p: F |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1995938147 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWP | Wipo information: published in national office |
Ref document number: 1995938147 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1995938147 Country of ref document: EP |